Home · Peptides · Taxorest
THE PEPTIDE APP FIELD GUIDE · Healing SERIES FIELD SPECIMEN
Healing CATEGORY

Taxorest

THE LUNG HEALER

A-11 Lung Bioregulator

Taxorest is a lung-derived bioregulator peptide extracted from alveolar tissue. It promotes surfactant production, supports regeneration of lung epithelial cells, and reduces pulmonary inflammation. It's used for COPD, pulmonary fibrosis, recovery from respiratory infections, and general lung health with aging or environmental exposure.

Taxorest
Taxorest
Taxorest

Taxorest Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

May 8, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Taxorest

◆

Is Taxorest FDA approved?

No. This profile records Taxorest as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Taxorest?

Dose: 20 mg daily (oral or subcutaneous).

MORE CONTEXT ›

Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Taxorest guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Surfactant Gene Activation

Upregulates surfactant proteins (SP-A, SP-B)

Pneumocyte Regeneration

Stimulates type II pneumocyte proliferation

Anti-Inflammatory

Suppresses NF-κB inflammatory mediators

Antioxidant

Enhances lung antioxidant enzyme activity

Those with COPD or chronic lung conditions
People recovering from respiratory infections
Anyone exposed to environmental pollutants
Smokers wanting lung support
Those with age-related respiratory decline

Taxorest Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.